Product NDC: | 0067-2030 |
Proprietary Name: | Excedrin |
Non Proprietary Name: | Acetaminophen, Aspirin (NSAID), and Caffeine |
Active Ingredient(s): | 250; 250; 65 mg/1; mg/1; mg/1 & nbsp; Acetaminophen, Aspirin (NSAID), and Caffeine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0067-2030 |
Labeler Name: | Novartis Consumer Health, Inc. |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part343 |
Marketing Category: | OTC MONOGRAPH NOT FINAL |
Start Marketing Date: | 20060927 |
Package NDC: | 0067-2030-50 |
Package Description: | 1 BOTTLE, PLASTIC in 1 CARTON (0067-2030-50) > 50 TABLET, FILM COATED in 1 BOTTLE, PLASTIC |
NDC Code | 0067-2030-50 |
Proprietary Name | Excedrin |
Package Description | 1 BOTTLE, PLASTIC in 1 CARTON (0067-2030-50) > 50 TABLET, FILM COATED in 1 BOTTLE, PLASTIC |
Product NDC | 0067-2030 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Acetaminophen, Aspirin (NSAID), and Caffeine |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20060927 |
Marketing Category Name | OTC MONOGRAPH NOT FINAL |
Labeler Name | Novartis Consumer Health, Inc. |
Substance Name | ACETAMINOPHEN; ASPIRIN; CAFFEINE |
Strength Number | 250; 250; 65 |
Strength Unit | mg/1; mg/1; mg/1 |
Pharmaceutical Classes |